Navigation Links
Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis

* | 33* |
|--------+-----------+-------------------------+--------------------|
| ACR 70 | 1 | 16* | 11* |
+-------------------------------------------------------------------+

* p<0.001

011 Trial
In the 24-week 011 phase III study, 220 adult patients with active RA who had previously failed at least one DMARD were randomized to
receive either CIMZIA(TM) 400 mg given subcutaneously every four weeks (n=111) or placebo (n=109). Patients were assessed for
improvement in signs and symptoms of RA. The primary endpoint of the 011 study was ACR20 responder rate, with secondary measures including ACR50 and ACR70 responder rates.

About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a progressive autoimmune disease which causes chronic inflammation of the joints. It is estimated that 5
million people suffer from RA globally,[2] with 0.3% to 1% of the population in industrialized countries suffering from RA.[3]

Prevalence is not split evenly between genders, since women are three times more likely to be affected than men.[4] Although it can affect
people of all ages, the onset of RA usually occurs between the ages of 35-55 years.[5]

Symptoms of RA include joint stiffness, joint pain, inflammation of the affected areas and an associated reduction in mobility. These
symptoms can be intermittent and vary in severity from patient to patient. In more severe cases RA can eventually lead to disability.
RA patients are also at a higher risk of developing other conditions, in particular heart disease, stroke, infections, lung problems and
osteoporosis.[6]

As there is currently no cure for RA, treatment goals centre on disease management. Treatment is aimed at controlling disease
progression, providing pain relief and reducing swelling, preventing joint damage and deformity and maintaining function of the a
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
3. Gabapentin Shown Effective for Fibromyalgia Pain
4. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
5. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
6. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
7. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
8. Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
9. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
10. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
11. In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression
Post Your Comments:
(Date:11/26/2014)... ALISO VIEJO, Calif. , Nov. 26, 2014 ... today announced that the U.S. Food and Drug ... to its New Drug Application (NDA) for AVP-825. ... of low-dose sumatriptan powder delivered intranasally utilizing a ... In the Complete Response letter, and consistent with ...
(Date:11/26/2014)... Scott Steiger lives in St. Louis ... for the past 20 years, he,s traveled extensively and prior to ... to six of the seven continents. Travel is a big part ... Photo - http://photos.prnewswire.com/prnh/20141126/161077 So when he ... idea of what,s required. His latest creation is the ...
(Date:11/26/2014)... 26, 2014 Zynerba Pharmaceuticals , Inc., ... innovative transdermal synthetic cannabinoid treatments, today announced that the ... Healthcare Conference 2014. The conference will be held December ... New York . Zynerba,s Chairman and ... pm on Tuesday, December 2. To listen ...
Breaking Medicine Technology:Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Steiger Has Created the First Pill Case Specifically Designed For Travel 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
... Dec. 9 BrainLAB, a manufacturer of software-driven ... St. Luke,s Hospital in Cedar Rapids, Iowa, has acquired ... Digital Lightbox© with TraumaCad(TM), a pre-operative planning and digital ... North America to acquire this technologically advanced duo. ...
... , INDIANAPOLIS, Dec. 9 tw telecom ... voice, Internet and data networking solutions for businesses in Indianapolis ... has selected the company to provide advanced voice, data and ... Indiana. Indiana Blood Center will also utilize tw telecom, ...
Cached Medicine Technology:St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services 2
(Date:11/27/2014)... 27, 2014 "As a nurse I ... effects of urinary incontinence," said an inventor from Whiting, ... this specialized accessory to prevent leakage and keep them ... absorb urine leakage. This prevents stains on pants, skirts ... The pad ensures that the individual has time to ...
(Date:11/27/2014)... Most babies and young children don,t need medicines if ... Administration says. Over-the-counter (OTC) cold and cough medicine ... because they could cause serious and potentially deadly side ... three colds a year, but children get them more ... to give them pain relievers, decongestants and other medicines, ...
(Date:11/27/2014)... In order to enable people to adapt ... an easy way to avoid touching a toilet seat and/or ... a prototype of the patent-pending Toilet Tamer, a device that ... and/or lid in a more sanitary manner. It avoids direct ... Overall, it promotes good hygiene and peace of mind. The ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Now that ... season has officially launched, Emassagechair.com has announced ... Monday Discount Event. , Negotiating on behalf of ... top massage chair brands, Emassagechair.com has generated significant buzz ... deals and biggest discounts yet. , Shoppers are excited ...
(Date:11/27/2014)... 2014 VogueQueen.com is making every effort ... across the world. As the premier online supplier of ... proud to release a huge selection of sexy prom ... it is also providing many beautiful styles in its ... at discounted prices. , “VogueQueen.com hopes to provide ...
Breaking Medicine News(10 mins):Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2
... June 3 OrthoSynetics(TM), the largest,provider of business ... two new members to its IT team. Allen ... and David D,Entremont has,been hired as senior network ... facet of our organization, and,the addition of these ...
... be issued under second round of Critical Challenges ... The Michael J. Fox,Foundation for Parkinson,s Research ... test non-invasive imaging technologies that would allow,scientists to ... the living brain. Such techniques hold potential to,serve ...
... Public Relations, WALTHAM, Mass., June 3 ... relations agencies, today announced,that its co-founders, Steve and ... J. Malloy Crystal Bell Lifetime Achievement Award last ... Ringer Awards., (Logo: http://www.newscom.com/cgi-bin/prnh/20080603/NETU111 ), ...
... Growths are able to maintain significant testosterone ... June 3 (HealthDay News) -- U.S. researchers ... prostate cancer becomes resistant to androgen-deprivation therapy, ... promotes prostate cancer growth. , Androgen therapy, ...
... seen in those who had relatives with disease, study finds ... that increases the risk of developing colorectal cancer also seems ... study indicates. , People with colorectal cancer who had close ... die or to have a recurrence after treatment, according to ...
... at Cold Spring Harbor Laboratory (CSHL) have taken the ... a newly published paper, they confirm that a gene ... in living mice that its deletion, inactivation or loss ... cancer closely related to common human epithelial cancers of ...
Cached Medicine News:Health News:OrthoSynetics(TM) Adds Two Experienced Pros to IT Team 2Health News:Michael J. Fox Foundation for Parkinson's Research Commits up to $2 million to Visualize Alpha-Synuclein Protein in the Brain 2Health News:Michael J. Fox Foundation for Parkinson's Research Commits up to $2 million to Visualize Alpha-Synuclein Protein in the Brain 3Health News:Steve and Paula Mae Schwartz Honored With Publicity Club of New England's Crystal Bell Award 2Health News:Androgen Production Continues in Prostate Cancer Tumors 2Health News:Family History Might Improve Odds Against Colon Cancer 2Health News:CSHL scientists trace causal link between a tumor suppressor gene and liver cancer 2Health News:CSHL scientists trace causal link between a tumor suppressor gene and liver cancer 3
Shoulder rasp...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
85 left angled suture passer....
45 right angled suture passer....
Medicine Products: